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Previous studies have shown that secondhand smoke induces lung function impairment and
increases proinflammatory cytokines. The aim of the present study was to evaluate the acute
effects of secondhand smokeonairwayacidificationandairwayoxidative stress in never-smokers.
In a randomized controlled cross-over trial, 18 young healthy never-smokers were assessed at
baseline and 0, 30, 60, 120, 180 and 240 min after one-hour secondhand smoke exposure at
bar/restaurant levels. Exhaled NO and CO measurements, exhaled breath condensate collection
(for pH, H2O2 and NO2
/NO3
 measurements) and spirometry were performed at all time-points.
Secondhand smokeexposure induced increases in serumcotinine andexhaledCO thatpersisted
until 240 min. Exhaled breath condensate pH decreased immediately after exposure (p < 0.001)
and returned to baseline by 180 min, whereas H2O2 increased at 120 min and remained increased
at 240min (pZ 0.001). No changes in exhaledNO andNO2/NO3were observed,while decreases intive pulmonary disease; EBC, exhaled breath condensate; eCO, exhaled carbon monoxide; FEF25e75%,
f exhaled nitric oxide; FEV1, forced expiratory volume in the first second; FVC, forced vital capacity;
ultivariate analysis of variance; NO2
, nitrate; NO3
, nitrite; PEF, peak expiratory flow; SD, standard
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Secondhand smoke and airways inflammation 173FEV1 (p< 0.001) and FEV1/FVC (p< 0.001)were observed after exposure and returned to baseline
by 180 min.
A 1-h exposure to secondhand smoke induced airway acidification and increased airway
oxidative stress, accompanied by significant impairment of lung function. Despite the reversal
in EBC pH and lung function, airway oxidative stress remained increased 4 h after the expo-
sure.
Clinical trial registration number (EudraCT): 2009-013545-28.
ª 2012 Elsevier Ltd. All rights reserved.Introduction
Secondhand smoke (SHS) or passive smoking is a risk factor
for several diseases. Previous clinical studies have shown
that SHS may represent a risk factor for lung cancer1 and
chronic obstructive pulmonary disease (COPD),2 and plays
a significant role in the development of ischemic heart
disease.3 The Third National Health and Nutrition Exami-
nation Survey in the US has also shown that SHS is associ-
ated with deterioration in lung function in adult females,
especially those with asthma.4 It is estimated that, before
the introduction of smoke-free policies, one employee in
the EU hospitality industry died every day from SHS expo-
sure, whereas exposure to passive smoking at home causes
the deaths of 16,600 nonsmokers each year, or one death
every 32 min5 Despite large anti-smoking campaigns, SHS
still represents a major health problem in many countries.
Several experimental trials have evaluated the acute
effects of active and passive smoking in subjects with and
without airway disorders. In a recent study we showed that
smoking two cigarettes can induce an acute oxidative stress
burst in the airways of asthmatic smokers.6 Moreover,
a single session of water pipe smoking leads to decreased
lung function, as expressed by forced mid-expiratory flow
(FEF25e75), and reduction in the levels of the fraction of
exhaled nitric oxide (FeNO).7 Our group has further shown
that a one-hour SHS exposure at bar/restaurant levels
induces significant decrements on lung function and
marked increases in inflammatory cytokines.2,8
Exhaled breath biomarkers have been extensively eval-
uated in current smokers, with and without airway disease.
FeNO levels are lower in healthy smokers compared to
healthy non-smokers,9 and smokers with allergic rhinitis
have lower values compared to non-smokers with allergic
rhinitis.10 Exhaled breath condensate (EBC) is a totally non-
invasive method for the evaluation of airways inflammation
and EBC pH levels, a robust and reproducible biomarker of
airway acidification,11 are lower in current smokers
compared to controls.12 Moreover, we have shown that
acute smoking induces acute airways acidification in asth-
matic current smokers.6 Additionally, EBC hydrogen
peroxide (H2O2) levels increased 30 min after smoke expo-
sure,13 whereas plasma nitrate (NO2
) and nitrite (NO3
)
levels decreased for a short time after smoking one
cigarette.14
Despite a robust body of evidence on the effects of
active smoking on airway inflammation, only a few studies
have investigated the effects of SHS on exhaled biomarkers.
A single study has provided experimental evidence of short-
term reduction of exhaled NO after a 1-h exposure to SHS ina separately ventilated chamber.15 A cross-sectional study
has shown that asthmatic allergic children with significant
exposure to SHS present lower FeNO levels compared to
those without SHS exposure,16 and a population-based
cross-sectional study in adults suggested that SHS expo-
sure is associated with lower FeNO levels in adults.17 A
small cross-sectional study has also evaluated oxidative
stress biomarkers in the EBC and has provided some
evidence for an effect of SHS the balance between oxida-
tive stress and antioxidant capacity of the lungs.18
However, the experimental data on the effects of SHS on
exhaled biomarkers are still limited.
The aim of the present randomized controlled cross-over
trial was to evaluate the effects of a one-hour exposure to
SHS at bar/restaurant levels on airway acidification (as
expressed by EBC pH), airway oxidative and nitrosative
stress (as expressed by H2O2 and NO2
/NO3
 levels, respec-
tively), exhaled carbon monoxide (eCO) and lung function.
Materials and methods
Study design
In a randomized controlled cross-over trial (EudraCT: 2009-
013545-28), 18 young healthy never smokers (9 males, 9
females, 32.7  6.0 years) with normal spirometry were
evaluated during an exposure and a control visit, separated
by 7 days. Subjects were non-atopic with a normal
spirometry, had not suffered a respiratory tract infection
for at least 8 weeks, and arrived in the lab following a 10-h
fast. In the exposure visit subjects were submitted to a 1-h
SHS exposure, whereas in the control visit they were
exposed to normal room air in a well-ventilated room. All
exposures started at 09:00 a.m. At baseline as well as at 0,
30, 60, 120, 180 and 240 min following each exposure
subjects were submitted sequentially to FeNO measure-
ment, eCO measurement, EBC collection and simple
spirometry, and blood samples were drawn, in that order.
The experimental protocol conformed to the standards of
the Declaration of Helsinki, was approved by the University
of Thessaly ethical review board (Approval No 164/2009),
and subjects provided written informed consent.
Second-hand smoke exposure
During the exposure visit, subjects were instructed to
remain seated at rest (i.e., reading a book or magazine) for
1-h inside a 6  5  4 m environmentally controlled
chamber (air temperature: 24 C; air velocity: 0.05 m s1;
174 K. Kostikas et al.humidity: 45%). The second-hand smoke (SHS) exposure was
adjusted at a carbon monoxide (CO) concentration of
23  1 ppm to meet levels previously reported for bar/
restaurant environments.2,19 Gradients of gas concentra-
tions and particle density were checked by continuous
measurement of different areas inside the chamber by
a CO90 (Martindale Electric Ltd., Watford, UK) COeCO2
analyzer. The desired CO concentration of the gas mixture
was achieved by combustion of cigarettes from various
popular brands (i.e., equal number of Camel, Davidoff
Classic, Gauloises Filter, Original Red Lucky Strike, Marl-
boro Reds, Prince Classic and Silk Cut Purple King Size
cigarettes). The cigarettes were lit and placed on ashtrays
to burn (just prior to reaching the filter) at different areas
in the chamber. When the desired CO concentration was
reached, the subject would enter the chamber.Study measurements
Spirometry
Spirometry was performed with a dry spirometer (KoKo
Legend; Ferraris, UK), and forced expiratory volume in the
first second (FEV1), forced vital capacity (FVC), FEV1/FVC
ratio, mid-expiratory flow (FEF25e75) and peak expiratory
flow (PEF) were recorded as absolute values and percent-
ages of predicted values, according to the American
Thoracic Society guidelines.20
Measurements of exhaled biomarkers
Exhaled CO was measured with a commercial analyzer (PICO
Smokerlyser; Bedfont, Rochester, UK). FeNO was measured
with a commercial NO analyzer (NIOX MINO; Aerocrine,
Solna, Sweden) at 50 mL/s exhalation flow rate.21
Exhaled breath condensate measurements
Exhaled breath condensate (EBC) was collected using
a commercially available condenser (EcoScreen; Viasys,
Hoechberg, Germany) according to the ATS/ERS recom-
mendations.22 Subjects rinsed their mouths with distilled
water and were asked to perform tidal breathing for 20 min
through a mouthpiece wearing a nose clip, while sitting
comfortably on a chair. Approximately 2 mL of condensate
were collected and were separated in two aliquots. The
first aliquot was used for the measurement of EBC pH,
immediately after EBC collection as previously described.22
Stable pH was achieved after deaeration with an inert gas
(argon, 350 ml/min for 10 min) and was measured using
a commercially available pH meter (Model 3510, Jenway,
Essex, UK).
The second aliquot of the EBC was immediately frozen in
80 C and was used for the rest of the measurements (i.e.
H2O2, and NO2
/NO3
). EBC H2O2 levels were measured
colorimetrically by means of horseradish peroxidase-cata-
lyzed oxidation of tetramethylbenzidine, according to the
method previously described by Gallati and Pracht.23
Briefly, 100 mL 3,30,5,50-tetramethylbenzidine and 10 mL
horseradish peroxidase (Sigma Chemicals, St Louis, MO,
USA) were reacted with 100 mL Serum or EBC for 20 min at
room temperature. Subsequently, the mixture was acidified
to pH 1 with 10 mL sulfuric acid. The reaction product was
measured spectrophotometrically at 450 nm usinga microplate reader (Bio-TeK, Instruments INC, Highland
Park, USA). A separate standard curve for H2O2 was con-
structed for each assay and all samples were analyzed in
triplicate and in one run to circumvent interassay variation.
Assays of H2O2 were performed on undiluted and non-
concentrated EBC samples. The lower limit of detection
(LOD), defined as the lowest concentration of the standard
curve was 0.1 mM for H2O2.
Nitrite/nitrate (NO2
/NO3
) measurements were per-
formed as previously described.24 Briefly, NO3
 was
measured as NO2
 after enzymatic conversion by NO3

reductase, and the total NO2
/NO3
 (converted NO3
 plus
NO2
/NO3
) was measured by using the Griess reaction, as
previously described.25 For the enzymatic conversion of
NO3
 to NO2
, aliquots of EBC were incubated for 30 min at
37 C with nitrate reductase (10 mU) and nicotinamide
adenine dinucleotide phosphohydrogenase (100 mM). Griess
reagent (100 ml; 5% v/v H3PO4 containing 1% w/v sulphanilic
acid and 0.1% w/v N-1-napthylethylenediamine) was then
added and samples incubated for a further 15 min (37 C).
The absorbance at 540 nm was measured using a microplate
reader (Bio-TeK, Instruments INC, Highland Park, USA). The
concentration of NO2
/NO3
 sum in each sample was deter-
mined by comparing the measured absorbance to a stan-
dard curve with known sodium nitrite (NaNO2)
concentrations. Each EBC sample was analyzed in tripli-
cate. The lowest detection limit of the method was 0.2 mM.
Serum cotinine measurements
Blood samples were immediately centrifuged and aliquots
were stored in 80 C. Serum cotinine was measured via
electron ionization mass spectrometric confirmatory anal-
ysis, as previously described.2Statistical analysis
Demographic data are presented as mean values with
standard deviation (SD). Normality of data was evaluated
with Kolmogorov Smirnov’s test. Sample size calculations
were conducted based on FEV1 values before and after
[4.9(0.4) vs. 4.5(0.3) in men and 3.7(0.4) vs. 3.2(0.3) in
women] a similar 1-h SHS exposure from a previous exper-
iment by our group.2 The resulting minimum required
sample size was 11 for 2-sided type 1 and type 2 errors of
5%. Exposure and control visits were performed using
a random allocation algorithm (SPSS 14.0.1, SPSS Inc.,
Chicago, Illinois). Analysis of data was performed using
a factorial multivariate analysis of variance (MANOVA)
incorporating three factors [visit (exposure, control), time
(0, 30, 60, 120, 180 and 240 min) and gender (male,
female)]. In the event of a significant F-ratio for a time
point and visit or interactive effect, post-hoc analyses using
Bonferroni corrections were employed to identify signifi-
cant differences over time within each group or between
groups. Correlations were performed using Spearman’s
rank correlation coefficient (rs). p values of <0.05 were
considered statistically significant. Statistical analysis was
performed with SPSS 14.0.1 (SPSS Inc., Chicago, IL), and
graphs were created with Graph Pad Prism 5 (GraphPad
Software Inc., La Jolla, CA).
Figure 1 Study design and times of exposure to secondhand smoke (SHS) and measurements.
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The design of the experiment is provided in Fig. 1. Spiro-
metric changes throughout the trial are presented in Table
1. Significant reductions in the values of FEV1 (F Z 38.416,
p < 0.001) and FEF25e75 (F Z 10.633, p < 0.001) were
observed immediately after the exposure and until 120 min,
whereas the FEV1/FVC ratio (F Z 14.765, p < 0.001) was
significantly reduced immediately after the exposure and
until 60 min, returning to baseline values thereafter. No
significant changes were observed in either FVC (FZ 0.270,
p Z 0.946) or PEF (F Z 1.274, p Z 0.300).
Changes in the levels of serum and exhaled biomarkers
throughout the trial are presented in Table 2. Significant
increases were observed in the levels of serum cotinine
(F Z 1937.475, p < 0.001) and exhaled CO (F Z 25.759,
p < 0.001; Fig. 2A); these increases were observed
immediately after the exposure and remained increased
until the end of the trial (240 min). A reduction in EBC pH
(F Z 5.755, p Z 0.001; Fig. 2B) was found immediately
after the exposure and remained significant until 120 min
after the exposure. EBC H2O2 levels were significantly
increased 120 min after the exposure, compared to base-
line, and remained significantly increased until 240 min
(F Z 2.645, p Z 0.036; Fig. 2C). No changes wereTable 1 Changes in spirometric values at each time point durin
Variable Visit Time points (min)
60 0 30
FEV1 (L) Exposure 4.11 (0.89) 3.73 (0.89)
a,b 3.79 (0.91
Control 4.11 (0.89) 4.11 (0.87) 4.10 (0.88
FVC (L) Exposure 5.05 (1.20) 5.03 (1.21) 5.01 (1.20
Control 5.03 (1.18) 5.03 (1.20) 5.02 (1.20
FEV1/FVC Exposure 0.82 (0.04) 0.74 (0.04)
a,b 0.76 (0.03
Control 0.82 (0.04) 0.82 (0.05) 0.82 (0.04
PEF (L/min) Exposure 9.89 (2.39) 9.70 (2.18) 9.43 (1.76
Control 9.54 (2.35) 9.52 (2.22) 9.48 (2.10
FEF25e75 (L) Exposure 3.98 (0.78) 3.58 (0.73)
a,b 3.57 (0.74
Control 4.03 (0.76) 4.03 (0.76) 4.08 (0.79
FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity; FEF
Data are presented as mean (SD).
a Statistical difference compared to 60.
b Statistical difference between visits.observed in FeNO levels (F Z 0.434, p Z 0.850) or EBC
NO2/NO3 levels (F Z 0.359, p Z 0.899) throughout the
trial. No differences were observed between in either
exhaled biomarkers or spirometry measurements between
genders.
EBC pH levels throughout the trial presented a modest
negative correlation with exhaled CO levels (rs Z 0.444,
p < 0.001) and a weak correlation with EBC NO2
/NO3
 levels
(rs Z 0.142, p Z 0.024), as well as a modest positive
correlation with the FEV1/FVC ratio (rsZ 0.352, p < 0.001)
and FEF25e75 (rsZ 0.180, pZ 0.004). Additionally, exhaled
CO levels and presented a significant negative correlation
with the FEV1/FVC ratio (rsZ 0.525, p < 0.001), whereas
EBC H2O2 levels presented a weak negative correlation with
FEF25e75 (rs Z 0.184, p Z 0.003). No other significant
correlations between exhaled biomarkers and/or spiro-
metric values were observed. Additionally, there were no
significant correlations between EBC biomarkers and serum
cotinine levels.Discussion
The current randomized controlled cross-over trial
revealed that a 1-h exposure of young healthy neverg the secondhand smoke exposure and control visits.
60 120 180 240
)a,b 3.89 (0.91)a,b 3.99 (0.91)a,b 4.10 (0.89) 4.10 (0.90)
) 4.10 (0.90) 4.11 (0.91) 4.11 (0.91) 4.11 (0.90)
) 5.01 (1.25) 4.98 (1.27) 5.00 (1.27) 5.02 (1.27)
) 5.01 (1.23) 4.99 (1.22) 5.01 (1.24) 5.02 (1.24)
)a,b 0.78 (0.04)a,b 0.81 (0.04) 0.83 (0.05) 0.83 (0.04)
) 0.82 (0.04) 0.83 (0.04) 0.83 (0.05) 0.82 (0.04)
) 9.25 (1.18) 9.54 (2.04) 9.43 (2.06) 9.54 (1.98)
) 9.34 (1.90) 9.43 (2.10) 9.65 (2.03) 9.52 (1.90)
)a,b 3.66 (0.71)a,b 3.81 (0.72)a,b 3.91 (0.73) 4.04 (0.77)
) 4.12 (0.80) 4.09 (0.74) 4.14 (0.76) 4.10 (0.73)
25e75: mid-expiratory flow; PEF: peak expiratory flow.
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176 K. Kostikas et al.smokers to SHS induced acutely airways acidification, as
expressed by EBC pH that subsided in 180 min. We also
observed a delayed increase in airway oxidative stress, as
expressed by EBC H2O2 that was evident for at least 4 h
after the exposure. These changes were accompanied by
increases in serum cotinine and exhaled CO levels that
persisted for at least 4 h, as well as by transient decreases
in FEV1, FEV1/FVC ratio and FEF25e75 that returned to
baseline levels 2 h after the exposure. We were additionally
able to find significant correlations between EBC pH,
exhaled CO and H2O2 levels with spirometric parameters
expressing airway obstruction. This finding provides indi-
cations of possible mechanisms regarding the development
of obstructive airways disease in healthy subjects exposed
to SHS. To our knowledge, this is the first controlled trial
that evaluates the acute effects of SHS on airway inflam-
mation biomarkers in young healthy never smokers.
Our study further contributes to the vast evidence
regarding the deleterious effects of SHS in the respiratory
system. For instance, SHS is an established risk factor for
the development of COPD.26 Lifetime exposure to SHS at
home and/or at work has been found to be associated with
respiratory symptoms especially dyspnea, shortness of
breath at rest and wheeze.27 The randomized cross-over
design of our study provides evidence that even a single
1-h exposure may lead to a transient, yet statistically and
possibly clinically significant, airway obstruction in
spirometry. These results support previous findings by our
group in a similar setting of SHS exposure,2 providing
additional information about the airway inflammatory
process that may underlie this obstructive disorder. Our
present findings are even more important given that the
observed increases in serum cotinine and exhaled CO levels
suggest a moderate and brief SHS exposure.2
Airway acidification, as expressed by EBC pH, is present
in patients with COPD and is associated with sputum neu-
trophilia and oxidative stress.24 Moreover, patients with
severe refractory asthma have lower values of EBC pH
compared with to patients with moderate asthma or
healthy subjects,28 whereas acute airway acidification is
present in acute asthma.29 In a cross-sectional study,
a subgroup of otherwise healthy smokers presented signif-
icant airway acidification (pH <7.2), but EBC pH did not
differ between smokers and non-smokers.30 The origin of
EBC pH reduction after smoke exposure is still under
debate, with some authors supporting a possible role for
salivary contamination,31 yet there is now evidence that
EBC pH expresses acidification of the airway at all levels,32
therefore expressing a deleterious effect in the whole
respiratory tract. Nevertheless, EBC pH represents the
most robust and reproducible biomarker in EBC,11 with
well-established normal values.33 Using the methodology
adopted in the present study, Paget-Brown et al. have
shown that only 6.4% of normal subjects present pH values
<7.4.33 Our findings indicate that exposure to SHS caused
a significant reduction in EBC pH, well below the afore-
mentioned “normal” range, however not reaching the
extreme levels of airway acidification reported in acute
asthma.29 This acidification was transient, returning to
baseline after 180 min, but the significant correlations of
EBC pH with FEV1/FVC ratio and FEF25e75% suggest
a possible role of airway acidification in the development
Figure 2 Changes in (A) exhaled CO (eCO) (B) exhaled breath condensate (EBC) pH and (C) exhaled breath condensate (EBC) H2O2
levels during the exposure and control visits. Error bars represent standard deviation. *Statistical difference compared to 60 min,
yStatistical difference between visits.
Secondhand smoke and airways inflammation 177of airway obstruction in our model of SHS exposure in
healthy young adults.
The second important finding of the present study is the
increase in exhaled H2O2, a biomarker of airway oxidative
stress. Despite measurement problems with exhaled breath
condensate that still need to be resolved, H2O2 is elevated
in patients with COPD34 and is a reproducible biomarker of
oxidative stress.35 The reproducible results in the control
visit of our experiment further support a role of this
biomarker in the evaluation of airway oxidative stress. The
increase of H2O2 in our experiment presented a different
pattern compared to airflow impairment and airway acidi-
fication, with its increase starting 2 h after exposure and
persisting at least until 4 h. This may be of importance,
since airway oxidative stress is one of the major pathogenic
mechanisms in COPD development.26 Previous studies have
shown that active smoking acutely increases exhaled
biomarkers of oxidative stress, in both healthy subjects and
asthmatic smokers.6 To our knowledge, this is the first study
that shows an increase in airway oxidative stress after
a brief moderate SHS exposure. This observation is impor-
tant, especially in relation to previous data from our group
showing that the same model of SHS led to increases of
systemic inflammatory cytokines that persisted until 3 h
after exposure.2 Taken together these findings suggest that
the deleterious effects of SHS may persist long after the
exposure.
Exhaled NO represents the most widely evaluated
exhaled biomarker today, being elevated in atopic asthma
and rhinitis,21 whereas smoking represents a significant
confounding factor in its evaluation, with asthmatic
smokers presenting lower values of FeNO compared to non-smokers.36 Total NO2
/NO3
 are end-products of NO metab-
olism and biomarkers of nitrosative stress that have been
found to be elevated in asthma.37 The effects of acute
smoking on exhaled NO levels are contradictory, with some
studies reporting reduction,38 no effect,6 or even increase39
of its levels in asthmatic smokers. In the present study,
exposure to SHS had no effect on FeNO or NO2
/NO3
 levels
during the 4 h follow-up. Previous cross-sectional studies
have provided evidence that FeNO is reduced in allergic
asthmatic children16 and asthmatic and non-asthmatic
adults17 with regular exposure to SHS, but these studies
have different design and our model of 1-h exposure in bar-
restaurant levels may differ significantly from the exposure
of their subjects. In a crossover study with a similar
experimental design to our study, Yates et al. have shown
that FeNO levels decrease rapidly in normal subjects
exposed to SHS when compared with sham exposure.
Differences in the study populations (higher age and
inclusion of former smokers in the study by Yates) and in
the measurement of FeNO (at 250 ml/min) may account in
part for the discrepancy in our results. Furthermore, FeNO
suppression in smokers is achieved through decreased NO
formation by reduced expression of inducible NO syn-
thase,40 mechanisms that may not be activated acutely by
the 1-h exposure to SHS in the young healthy never-smokers
of our population.
A weak correlation between EBC pH and NO2
/NO3
 was
additionally observed in our population. We believe that
this may be associated with a trend for a reduction of NO2
/
NO3
 in the exposure group (see Table 2, Columns
60e240 min) that, however, did not approach statistical
significance. This may reflect a trend for reduction in NO
178 K. Kostikas et al.production in the presence of low pH that has been re-
ported in previous studies.24,29 Another possible explana-
tion for that may be that the 1-h exposure to SHS in our
model may not be adequate for the suppression of FeNO
and NO-related products in the exhaled air of our study
participants, and this needs to be investigated in further
studies with longer exposure.
In conclusion, the present randomized controlled cross-
over trial has revealed that a 1-h exposure to SHS induced
airway acidification and increased airway oxidative stress,
accompanied by significant impairment of lung function in
young healthy never-smokers. Despite the reversal in EBC
pH and lung function, airway oxidative stress remained
increased 4 h after the exposure, representing a possible
mechanism for the persistence of the deleterious effects of
secondhand smoke after the end of the exposure.
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